0271-3683 |
CURRENT EYE RESEARCH (PRINT) |
MEDICINA II |
A3 |
2017-2020 |
2196-2995 |
CURRENT EPIDEMIOLOGY REPORTS |
CIÊNCIAS BIOLÓGICAS II |
A4 |
2017-2020 |
2196-2995 |
CURRENT EPIDEMIOLOGY REPORTS |
SAÚDE COLETIVA |
A4 |
2017-2020 |
2196-2995 |
CURRENT EPIDEMIOLOGY REPORTS |
BIOTECNOLOGIA |
A4 |
2017-2020 |
1573-4080 |
CURRENT ENZYME INHIBITION |
BIOTECNOLOGIA |
B3 |
2017-2020 |
1573-4080 |
CURRENT ENZYME INHIBITION |
MEDICINA I |
B3 |
2017-2020 |
1573-4080 |
CURRENT ENZYME INHIBITION |
MATERIAIS |
B3 |
2017-2020 |
1573-4080 |
CURRENT ENZYME INHIBITION |
INTERDISCIPLINAR |
B3 |
2017-2020 |
1573-4080 |
CURRENT ENZYME INHIBITION |
QUÍMICA |
B3 |
2017-2020 |
2666-2159 |
CURRENT ENVIRONMENTAL MANAGEMENT |
BIOTECNOLOGIA |
B4 |
2017-2020 |
2666-2159 |
CURRENT ENVIRONMENTAL MANAGEMENT |
ENGENHARIAS I |
B4 |
2017-2020 |
1574-8855 |
CURRENT DRUG THERAPY (HILVERSUM) |
QUÍMICA |
B2 |
2017-2020 |
1574-8855 |
CURRENT DRUG THERAPY (HILVERSUM) |
FARMÁCIA |
B2 |
2017-2020 |
1568-007X |
CURRENT DRUG TARGETS. CNS & NEUROLOGICAL DISORDERS |
MEDICINA I |
C |
2017-2020 |
1389-4501 |
CURRENT DRUG TARGETS (PRINT) |
MEDICINA I |
A3 |
2017-2020 |